Skip to content
Disclosery

EXANE DERIVATIVES: FTV position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on FTV, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 2,713 FTV shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 2,713 shares
    Change vs previous 13F -746 shares

    0.08% of the 13F portfolio, value $147,503.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 3,459 shares
    Change vs previous 13F -1,203 shares

    0.06% of the 13F portfolio, value $210,744.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 4,662 shares
    Change vs previous 13F -3 shares

    0.09% of the 13F portfolio, value $355,651.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 4,665 shares
    Change vs previous 13F +3,963 shares

    0.08% of the 13F portfolio, value $329,197.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 702 shares
    Change vs previous 13F -64 shares

    0.01% of the 13F portfolio, value $49,546.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 766 shares
    Change vs previous 13F +118 shares

    0.02% of the 13F portfolio, value $54,108.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 648 shares
    Change vs previous 13F not available

    0.01% of the 13F portfolio, value $45,889.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).